Legal & General Group PLC Logic Bio Therapeutics, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 12, 2021	SELL	$4.03 - $7.57 $7,902 - $14,844	-1,961 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$6.8 - $9.16 $646 - $870	-95 Reduced 4.62%	1,961 $14,000
Q4 2020 Feb 12, 2021	BUY	$5.29 - $9.1 $2,904 - $4,995	549 Added 36.43%	2,056 $16,000
Q3 2020 Nov 13, 2020	SELL	$5.41 - $9.45 $3,370 - $5,887	-623 Reduced 29.25%	1,507 $14,000
Q2 2020 Aug 14, 2020	BUY	$4.25 - $8.46 $2,120 - $4,221	499 Added 30.59%	2,130 $18,000
Q4 2019 Feb 13, 2020	BUY	$7.01 - $11.01 $2,607 - $4,095	372 Added 29.55%	1,631 $12,000
Q4 2018 Feb 15, 2019	BUY	$7.88 - $17.98 $9,920 - $22,636	1,259 New	1,259 $13,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.